Commentary

With apologies to filmmaker Michael Moore, Wisconsin is no "Sicko" when it comes to quality healthcare, but there is always room for improvement, according to Inside Wisconsin columnist Tom Still. One case in point is a new and improved data-management and claims-processing system for Medicaid....

In a post 9/11 and Hurricane Katrina environment, and with frequent warnings about more domestic terrorist attacks, one would think states, counties, and municipalities would be prepared for emergencies, including the deft use of technology. That's not necessarily so, according to columnist James Carlini, and...

Magazines and think-tanks are busy with their annual summer ritual - their “best places” rankings - and their ratings of Wisconsin's business climate are mostly negative, according to Inside Wisconsin columnist Tom Still. The mediocre-to- poor business rankings are a cause for concern, especially because...

All of us at some point during our careers have worked with someone who is unpleasant, difficult to get along with, and maybe even has undermined our efforts, stolen our ideas, or taken credit for our work. Even worse is working in an organization with...

When it comes to venture capital, higher interest rates aren't necessarily a death sentence, according to columnist Ogan Gurel. In this edition of Med Tech Futures, he contends that higher rates tend to point investors toward higher potential return, higher-risk investments. That means the life...

Taking aim at IT workorce and other labor practices, columnist James Carlini assails the practice of "labor dumping," which like product dumping is eroding the economic stability of the middle class. In this edition of Carlini's Comments, he explains why labor dumping is yet another...

There is a multi- billion dollar gap between the Senate and Assembly budgets, but the real bargaining over the state's two-year spending blueprint has begun in conference committee. In this edition of Inside Wisconsin, columnist Tom Still would like to see lawmakers follow a few...

Unlike the biotech industry, where the Midwest is playing catch-up to the coasts, the Midwest's nanotech industry is robust and on par with developments in other leading areas in the U.S. In this edition of Yer Biotech Blues, columnist Michael Rosen touts the multiple examples...

For anyone interested in open source software but operating under the assumption that it's "free," attorney and columnist Deborah Wilcox has some upsetting news. In this edition of IP Online, she explains why open source is anyting but free, and she advises companies to develop...

The fate of three stem cell patents held by the Wisconsin Alumni Research Foundation hangs in the balance before the U.S. Patent and Trademark Office, and opinions vary wildly as to whether they will be upheld, weakened, or overturned. In this WTN guest column, the...